Sunday, December 16, 2018 4:56:15 PM
Source: https://cann10.com/cannareet
- I noticed that the Cannareet page on Cann10's website has been recently updated
- Please note that I have added the two green rectangle highlights to the snip-its above to identify the important paragraphs on the page that I think relate to the potential of Cannareet to help Cann10 enter the North American market and license the product and its technologies to operators such as potential BLDV clients; like Dharma once they receive approval. Key words are: pharma grade.
Go BLDV!
Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
